Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 62.46 CNY -6.09% Market Closed
Market Cap: 12B CNY
Have any thoughts about
Shanghai Haohai Biological Technology Co Ltd?
Write Note

Shanghai Haohai Biological Technology Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai Haohai Biological Technology Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Retained Earnings
ÂĄ2.8B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Retained Earnings
-ÂĄ57.7B
CAGR 3-Years
-28%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Retained Earnings
ÂĄ8.2B
CAGR 3-Years
70%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Retained Earnings
ÂĄ10.2B
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
32%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Retained Earnings
ÂĄ29.1B
CAGR 3-Years
35%
CAGR 5-Years
61%
CAGR 10-Years
48%
Imeik Technology Development Co Ltd
SZSE:300896
Retained Earnings
ÂĄ3.1B
CAGR 3-Years
56%
CAGR 5-Years
84%
CAGR 10-Years
N/A
No Stocks Found

Shanghai Haohai Biological Technology Co Ltd
Glance View

Market Cap
12B CNY
Industry
Biotechnology

Shanghai Haohai Biological Technology Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Shanghai, Shanghai and currently employs 1,892 full-time employees. The company went IPO on 2015-04-30. Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The firm mainly operates businesses in Mainland China.

Intrinsic Value
97.48 CNY
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Shanghai Haohai Biological Technology Co Ltd's Retained Earnings?
Retained Earnings
2.8B CNY

Based on the financial report for Dec 31, 2023, Shanghai Haohai Biological Technology Co Ltd's Retained Earnings amounts to 2.8B CNY.

What is Shanghai Haohai Biological Technology Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
11%

Over the last year, the Retained Earnings growth was 15%. The average annual Retained Earnings growth rates for Shanghai Haohai Biological Technology Co Ltd have been 11% over the past three years , 11% over the past five years .

Back to Top